Related Experiment Video
Updated: Aug 15, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours
Dong Li Guo1, Ji Zhang, Siu Tsan Yuen
1Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong.
Abstract:
EphB2, a receptor tyrosine kinase regulated by the beta-catenin/Tcf4 complex, is expressed in the proliferative compartment of mouse intestine and regulates bidirectional migration of intestinal precursor cells in the crypt-villus axis through repulsive interaction with Ephrin-B ligands. Recently, it has been shown that reduction of EphB activity accelerates colon tumour progression in the Apc(Min/+) mice. In this study, we examined the expression of EphB2 in normal colon, adenomas, primary colorectal cancers (CRCs), lymph node metastases and liver metastases using immunohistochemistry on tissue microarrays. In addition, EphB2 was overexpressed in SW480 colon cancer cells to study its effect in vitro. We found that EphB2 was expressed in 100% of normal colon crypt base cells, 78% of adenomas, 55.4% of primary CRCs, 37.8% of lymph node metastases and 32.9% of liver metastases (all differences were statistically significant at P < 0.001 compared with primary CRCs). Patients with CRCs that lose EphB2 expression had more advanced tumour stage (P = 0.005), poor differentiation (P < 0.001), poor overall survival (P = 0.005) and disease-free survival (P = 0.001), with the latter being independent of tumour stage. In vitro studies showed that overexpression of EphB2 inhibited colon cancer cell growth in colony formation assay and activation of EphB2 receptor inhibited colon cancer cell adhesion and migration. Our data demonstrated a progressive loss of EphB2 expression in each critical step of colon carcinogenesis, including the onset of invasion, dedifferentiation and metastasis which are paralleled by adverse patient outcome. EphB2 may achieve its tumour suppressor function through regulation of cell survival, adhesion and migration.
Insights
Loss of EphB2 receptor tyrosine kinase expression correlates with advanced colorectal cancer (CRC) and poor patient survival. This suggests EphB2 acts as a tumor suppressor by regulating cell growth, adhesion, and migration in colon carcinogenesis.
Area of Science:
- Molecular biology
- Cancer research
- Cell biology
Background:
- EphB2 receptor tyrosine kinase is crucial for intestinal precursor cell migration.
- Reduced EphB activity accelerates colon tumor progression in Apc(Min/+) mice.
- EphB2 is regulated by the beta-catenin/Tcf4 complex.
Purpose of the Study:
- To investigate EphB2 expression patterns in normal colon, adenomas, and colorectal cancers (CRCs) with varying metastatic potential.
- To determine the correlation between EphB2 expression levels and clinicopathological features, including tumor stage, differentiation, and patient survival.
- To elucidate the functional role of EphB2 in colon cancer cell growth, adhesion, and migration in vitro.
Main Methods:
- Immunohistochemistry on tissue microarrays to assess EphB2 expression in patient samples.
- Overexpression of EphB2 in SW480 colon cancer cells for in vitro functional studies.
- Colony formation assays to evaluate cell growth inhibition.
- Cell adhesion and migration assays to assess EphB2 receptor activation effects.
Main Results:
- EphB2 expression significantly decreases progressively from normal colon crypt base cells (100%) to adenomas (78%), primary CRCs (55.4%), lymph node metastases (37.8%), and liver metastases (32.9%).
- Loss of EphB2 expression is strongly associated with advanced tumor stage (P = 0.005), poor differentiation (P < 0.001), and reduced overall and disease-free survival (P = 0.005 and P = 0.001, respectively).
- In vitro, EphB2 overexpression inhibited colon cancer cell growth, while EphB2 receptor activation reduced cell adhesion and migration.
Conclusions:
- EphB2 expression is progressively lost during colon carcinogenesis, invasion, dedifferentiation, and metastasis.
- Decreased EphB2 expression serves as a significant prognostic marker for adverse patient outcomes in CRC.
- EphB2 likely functions as a tumor suppressor in the colon by modulating cell survival, adhesion, and migration.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle
Abnormal Proliferation
